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Objective(s): Oscillometric blood pressure (BP) measurement devices frequently replace the 2 
standard mercury sphygmomanometer. Comparisons of oscillometric devices are rare, but 3 
their agreement is important to ensure comparability of BP data. This study aims to compare 4 
two oscillometric devices, Datascope Accutorr Plus and Omron HEM-705CP II and to develop 5 
BP conversion models. 6 
Methods: A sample of 109 adults aged 21 to 64 years had alternate same-arm BP 7 
measurements according to the International Protocol revision 2010 for the validation of BP 8 
measuring devices in adults of the European Society of Hypertension. 9 
Results: 327 BP measurement pairs were obtained. Datascope systolic BP (SBP) pairs in mmHg 10 
were optimal (<120) for n=188, prehypertensive (120-139) for n=107 and hypertensive (≥140) 11 
for n=32 (diastolic BP (DBP) <80 n=261/80-89 n=57/≥90 n=9). Mean Omron values were higher 12 
and the difference increased with BP (mean differences Omron minus Datascope within BP 13 
ranges were in mmHg: SBP 1.1 ± 4.7, 3.0 ± 5.5 and 9.3 ± 6.7; DBP: 0.2 ± 3.3, 2.3 ± 3.4 and 5.1 ± 14 
3.9 mmHg) and pulse pressure (pulse pressure >50 mmHg SBP difference 5.6 ± 6.3). Prevalence 15 
of hypertensive BP with Omron was 11%, with Datascope 5%. Bidirectional conversion models 16 
of SBP and DBP values include BP, pulse pressure, age, sex and the difference in the ratio of 17 
cuff-width-to-arm-circumference. 18 
Conclusions: The disagreement of oscillometric devices can reach a magnitude that could be of 19 
interest for clinical and epidemiological contexts. Conversion formulas with BP, pulse pressure, 20 
sex, age and the cuff-width-arm-circumference-ratio may help to improve comparability.  21 




Hypertension is a widespread risk factor for cardiovascular diseases and a major determinant 2 
of mortality and morbidity [1, 2]. Estimates of hypertension prevalence and incidence are 3 
important for decisions in health policy and prevention and therefore accurate blood pressure 4 
(BP) measurement is a prerequisite for many interventions.     5 
During the past years the oscillometric BP measurement technique increasingly replaced the 6 
auscultatory mercury sphygmomanometry in epidemiological studies [3, 4] and has been used 7 
also in clinical trials and long-outcome studies [5-7]. Although the mercury 8 
sphygmomanometer continues to be the gold standard for BP measurement, it is frequently 9 
replaced by oscillometric devices because of the toxicity of mercury [8] and observer bias [9] 10 
which are frequent with the auscultatory technique. Validation of new oscillometric  BP 11 
devices  is obtained through comparison with the gold standard mercury sphygmomanometer 12 
and accuracy is evaluated with criteria specified in protocols of international societies, i.e. the 13 
European Society of Hypertension International Protocol revision 2010 for the validation of BP 14 
measuring devices (ESH-IP2), and the protocols of the British Hypertension Society (BHS) and 15 
the American Association for the Advancement of Medical Instrumentation (AAMI) [10-12].  16 
However, passing these validation protocol criteria still allows for considerable disagreement 17 
between devices.  For example, to pass the AAMI criteria for SBP and DBP, mean differences 18 
between measurement pairs should be ≤5 mmHg with a standard deviation of ≤8 mmHg while 19 
for BHS grade A validation, the absolute difference between measurement pairs should be 20 
within 5 mmHg in at least 60% of measurement pairs, within 10 mmHg in ≥85% and within 15 21 
mmHg in ≥95%. The ESH-IP2 additionally requires an individual-based analysis of agreement 22 
and specifies criteria based on the frequencies of pairs ≤5 mmHg and ≥15 mmHg for every 23 
individual. The results of many validation studies are summarized on a website 24 
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(http://www.dableducational.org). Most importantly, since oscillometric devices operate with 1 
their own model-specific algorithms to calculate BP values and since the manufacturer-2 
provided cuffs and cuff selection instructions also differ, measurement agreement between 3 
oscillometric devices which were successfully validated against the mercury 4 
sphygmomanometer gold standard cannot be taken for granted. 5 
The present study addresses this issue by comparing two oscillometric devices, the Datascope 6 
Accutorr Plus and the Omron HEM-705CP II. The Datascope Accutorr Plus is a device designed 7 
for professional use and is employed in two representative health surveys in Germany, the 8 
German Health Interview and Examination Survey for Children and Adolescents (KiGGS) and 9 
the German Health Interview and Examination Survey for Adults (DEGS1) [13, 14] as well as 10 
other health surveys [15, 16], while the Omron device, which is designed for professional as 11 
well as home BP measurement is used by several regional German epidemiological studies 12 
with a focus on cardiovascular epidemiology [17-19]. Both devices had favorable results in 13 
several validation studies compared to the mercury sphygmomanometer gold standard [20-25] 14 




This methodological study compared two oscillometric devices: the Datascope Accutorr Plus 2 
(Accutorr Plus™, Datascope Corp., Mahwah, New Jersey, USA) and the Omron HEM-705CP II 3 
(Omron Healthcare UK Ltd, Fox Milne, Milton Keynes, MK15 0DG).  4 
A sample of 109 adults aged 21 to 64 years (70 women, 39 men) was recruited at a scientific 5 
institute with mainly white collar workers. Informed consent and assent were obtained from 6 
all participants. Persons with arrhythmia or a pacemaker (ascertained by personal interview 7 
and pulse palpation) were excluded from the study [10]. The study was approved by the 8 
Ethical Committee of Charité University Medicine Berlin and by the German Federal 9 
Commissioner for Data Protection and Freedom of Information.  10 
The comparison of Datascope and Omron was performed in a sequence of serial same-arm BP 11 
measurements alternating the devices and their manufacturer-provided cuffs. The study 12 
design followed the principles outlined in the ESH-IP2 [10].  At the same time, the study 13 
protocol closely followed the protocols of the German Health Interview and Examination 14 
Survey for Adults (DEGS1) which employed the Datascope Accutorr Plus, and the protocol of a 15 
regional epidemiologic study with a focus on cardiovascular diseases, the Kooperative 16 
Gesundheitsforschung in der Region Augsburg study (KORA-2000) which has served as model 17 
for several subsequent cardiovascular cohort studies in Germany [4, 17, 18]. These study 18 
protocols are in line with the standardization instructions of the ESH-IP2, but since the 19 
manufacturer´s instructions for the selection of individual cuffs for a given arm circumference 20 
(AC) slightly overlapped (e.g. instructions allowed the use of the small but also the medium 21 
cuff for AC 28.0 cm), this overlap was removed following the DEGS1 and KORA-2000 protocols 22 
in order to make instructions unequivocal. 23 
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A standardized measurement environment was created in a quiet study room. The participants 1 
sat and relaxed for at least five minutes on a height adjustable chair, their back supported. The 2 
elbow was slightly bent and lying on a table at the level of the right atrium. Both feet were 3 
straight on the floor and legs were not crossed. Manufacturer-provided cuffs were used for 4 
each device. The correct cuff size was identified by measuring the upper AC between the 5 
acromion and the olecranon.  6 
For the Datascope Accutorr Plus three different cuffs were available with a bladder size of 7 
10.6x23.9 cm for ACs ranging from 21.0-27.9 cm (manufacturer instruction: 20.5-28.5 cm), a 8 
bladder size of 13.5x30.7 cm for ACs 28.0-35.9 cm (manufacturer: 27.5-36.5 cm) and a bladder 9 
size of 17.0x38.6 cm for ACs 36.0-46.0 cm (manufacturer: 35.5-46 cm). The Omron device was 10 
supplied with two cuff sizes: 14x48 cm for ACs 22.0-31.9 cm (manufacturer: 22-32 cm) and 11 
16x65 cm for ACs 32.0-42.0 cm (manufacturer: 32-42 cm). 12 
A Datascope Accutorr Plus and an Omron HEM-705CP II device with a set of manufacturer-13 
provided cuffs were randomly selected from the study equipment of DEGS1 and KORA-2000. 14 
Both devices give BP readings to the nearest 1 mmHg and were checked for technical 15 
correctness by the German Federal Institute of Science and Technology. 16 
Nine sequential same-arm BP measurements were performed in each participant starting with 17 
the Datascope device. The first measurement with each device was not used for analysis. 18 
Measurements were at least 30 s apart to avoid venous congestion but not more than 60 s to 19 
avoid increased variability. 20 
The analysis was based on BP measurement pairs. Each Omron measurement was compared 21 
to the nearer of the previous and next Datascope measurement. The Datascope measurement 22 
that was closest to the Omron measurement was used to define a measurement pair.  23 
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The device differences in systolic (SBP) and diastolic (DBP) BP were calculated as Omron minus 1 
Datascope and the cuff-width/arm-circumference-ratio (CW/AC-R) and the cuff-length/arm-2 
circumference-ratio (CL/AC-R) were computed for both devices.  3 
BP categories were defined as optimal BP <120/80 mmHg, prehypertensive BP 120-139/80-89 4 
mmHg and hypertensive BP ≥140/90 mmHg [1]. Pulse pressure was calculated as SBP minus 5 
DBP for both devices. The mean and standard deviation (SD) of device differences was 6 
ascertained and stratified by sex, age, BP categories, AC groups, cuff sizes, tertiles of CW/AC-R 7 
and CL/AC-R as well as the differences in CW/AC-R and CL/AC-R of the devices (≤0% and >0%) 8 
and Wilcoxon signed rank tests were performed to check for the significance of measurement 9 
differences. The frequencies of SBP and DBP differences within 5, 10, 15 and >15 mmHg were 10 
calculated and the differences were plotted against the average BP values of both devices 11 
(Bland-Altman plots). The prevalence of hypertensive BP values was determined for both 12 
devices and Cohen’s Kappa was calculated to assess agreement of allocation to hypertension 13 
status. Prediction of Datascope SBP and DBP based on Omron and vice versa was attempted 14 
through linear regression analysis. Variables initially included were: the value of SBP or DBP of 15 
the corresponding device, sex, age, AC, pulse pressure and, since they were highly correlated,  16 
the cuff sizes, the CW/AC-R, the CL/AC-R and the differences in CW/AC-R and CL/AC-R were 17 
each at a time included separately. Starting from these four full models, all non-significant 18 
variables were excluded in a stepwise order until only the significant factors (p<0.05) 19 




A total of 109 participants completed the study resulting in 327 blood pressure measurement 2 
pairs for analyses. Basic characteristics of the study population are summarized in Table 1.  3 
The mean difference of Omron-SBP minus Datascope-SBP was 2.5 ± 5.7 mmHg and 0.7 ± 3.5 4 
mmHg for DBP (p<0.05), respectively. Moreover, the SBP difference was larger in men than in 5 
women (4.0 ± 6.1 mmHg vs. 1.7 ± 5.3 mmHg; p<0.05) and increased with age (from 2.4 ± 4.7 6 
mmHg for age group <40 years to 4.7 ± 8.0 mmHg for > 60 years; p<0.05).  Moreover, SBP 7 
disagreement was particularly high for hypertensive BP (BP ≥140 mmHg: mean difference ± SD 8 
9.3 ± 6.7 mmHg; p<0.05) (Fig. 1) and in the highest Omron pulse pressure tertile (pulse 9 
pressure >50 mmHg: mean difference ± SD 5.6 ± 6.3 mmHg; p<0.05). The pattern of 10 
differences for DBP was similar. Men had a slightly higher mean difference and the difference 11 
decreased with age, but these findings were not significant. Again, the DBP difference 12 
significantly increased with DBP but only a few measurements were within the hypertensive 13 
range (Fig. 2). The CW/AC-R of Omron was higher in 96.3% of participants meaning that the 14 
Omron cuff was larger in relation to AC than the corresponding Datascope cuff. For the few 15 
cases in whom the Omron cuff was smaller (resulting in a CW/AC-R difference <0) the 16 
measurement disagreement in SBP and particularly in DBP was high (CW/AC-R <0: SBP 17 
difference 3.0 ± 3.7 mmHg (p<0.05) and 4.1 ± 4.3 mmHg for DBP (p<0.05), respectively) (Tab. 18 
2). 19 
SBP differences were within ± 5 mmHg in 66% of measurement pairs, within ± 10 mmHg in 20 
91% and were less than 15 mmHg in 98% (for DBP 89%, 99% and 100%) (Tab. 2).  21 
Hypertension prevalence by device 22 
The prevalence of hypertensive BP based on Omron measurements was noticeably higher as 23 
opposed to Datascope (11 vs. 5%). From 110 measurement pairs that were classified as 24 
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prehypertensive with Datascope, 21% were labeled hypertensive with Omron whereas only 3% 1 
were categorized hypertensive with Datascope but were prehypertensive according to Omron. 2 
Cohen’s Kappa amounted to 0.67 (p<0.05) (data not shown).  3 
Conversion of SBP and DBP from Omron HEM-705CP II to Datascope Accutorr Plus and vice 4 
versa 5 
The models for the conversion models of BP values from one device to the other were 6 
developed through linear regression analysis. Parameter selection was based on previous 7 
studies on factors influencing oscillometric measurements [26-29]. In addition, various 8 
variables reflecting cuff sizes and cuff selection rules were considered since manufacturer-9 
provided cuffs as well as cuff selection rules were not equivalent for the two devices and could 10 
have influenced measurements [30-36]. The final models containing only the significant factors 11 
are shown in Table 3 and these can be used for equations to convert blood pressure values 12 
from Datascope to Omron and vice versa before comparisons of BP data are performed. For 13 
example, the comparability of BP data gathered within the specified German studies could be 14 





This study compares two frequently used upper arm oscillometric blood pressure devices, 2 
Datascope Accutorr Plus and Omron HEM-705CP II, which had both previously shown good 3 
agreement with gold standard mercury sphygmomanometer measurements according to 4 
international validation protocols [20-25]. When directly comparing Datascope Accutorr Plus 5 
and Omron HEM-705CP II measurements in this study, agreement of DBP remained good 6 
(mean difference 0.7 ± 3.5 mmHg) but mean SBP difference was 2.5 ± 5.7 mmHg and higher in 7 
participants with elevated SBP, leading to a higher hypertension prevalence estimate when BP 8 
was measured with Omron as compared to Datascope (11% vs. 5%). The formulas for the 9 
conversion of BP values from one device to the other include BP, pulse pressure, sex, age, arm 10 
circumference and the difference in CW/AC-R.  11 
 12 
Both devices passed validation protocols of international societies, i.e.  the Datascope device 13 
was validated according to the protocols of the AAMI and BHS [20-22] and Omron was further 14 
evaluated with the ESH criteria [23-25]. In comparison with the mercury sphygmomanometer, 15 
Datascope Accutorr Plus SBP was on average almost identical in two studies in adults and 16 
slightly lower in children (device-observer difference 0.0 ± 7.9 mmHg [20]; 0.1 ± 7.5 mmHg [21] 17 
and -0.9 ± 4.3 mmHg [22]). Datascope DBP was lower in these three studies compared to the 18 
auscultatory method with a mercury sphygmomanometer (device-observer difference -0.4 ± 19 
5.8 mmHg [20]; -2.5 ± 5.2 mmHg [21] and -1.3 ± 6.5 mmHg [22]). For the specific Omron model 20 
HEM-705CP II no validation studies are available, but three validations were conducted for the 21 
model Omron 705IT, which was declared equivalent [37]. 22 
The Omron 705IT SBP was on average slightly higher than mercury sphygmomanometer 23 
readings by 0.6 ± 6.0 mmHg in one validation study in adults [23] and slightly lower by 0.2 ± 4.5 24 
mmHg in a second validation study in adults [24]. In children the Omron 705IT SBP was higher 25 
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by 4.0 ± 4.8 mmHg [25]. Moreover, another 705IT equivalent, the Omron M6 upper arm device 1 
(HEM-7001-E) was separately validated and consistently slightly overestimated SBP by 2 
approximately 1 mmHg. DBP on the other hand was underestimated by this Omron device in a 3 
similarly magnitude (around 1 mmHg) in all studied groups (adults, obese adults, elderly) [38-4 
40]. 5 
In addition, the predecessor model Omron HEM-705CP was evaluated in validation studies and 6 
furthermore in studies with modifications of the formal validation protocols (e.g. regarding 7 
measurement procedure, cuff selection or subject/ BP requirements). Again, SBP was mostly 8 
overestimated and DBP predominantly underestimated [41-46]. However, it is not clear if any 9 
alterations of the measurement algorithm were performed between the Omron HEM-705CP 10 
and its successor HEM-705CP II that could have had an effect on the measurements. Hence, 11 
the results of these studies are may not be transferable.  12 
Thus, although both oscillometric devices passed international validations, underestimation of 13 
SBP by one device and overestimation by the other device may result in a surprising difference 14 
if the devices are compared to one another. Secondly, validation studies often used the same 15 
cuffs for the auscultatory and oscillometric measurements, but in our study the manufacturer-16 
provided cuffs were applied which differ in size and ratios of cuff width and cuff length to AC. 17 
Last but not least, though both devices are based on the oscillometric technique, 18 
manufacturers develop their own algorithms to calculate SBP and DBP from pulse oscillations 19 
in the cuff. For this reason some measurement disagreement between oscillometric devices is 20 
likely [47]. 21 
Not all validation studies for Datascope and Omron report on the device performance at 22 
different blood pressure levels. Similarly to other studies, we observed an increasing device 23 
disagreement with rising SBP in this study [41, 44, 48].  For Datascope, two studies found an 24 
increasing disagreement with the gold standard mercury sphygmomanometer at SBP extremes 25 
12 
 
(>190 mmHg) [20, 21], whereas for Omron SBP measurement difference increased at higher 1 
SBP in one study, but agreement was similarly good within all BP ranges in another study [23, 2 
24]. 3 
For DBP, all three validation studies with Datascope found a similarly good agreement over the 4 
whole DBP range, whilst the Omron 705IT as well as the Omron M6 showed either an 5 
increasing disagreement at low [24, 38] or at high [23, 25, 39] BP levels. Moreover, one study 6 
with the M6 found that with increasing BP a disagreement >10 mmHg was more prevalent in a 7 
group with obese adults but not in the group with normal adults [40]. 8 
However, for many oscillometric devices the measurement differences increase with rising BP 9 
and a study comparing six electronic devices with a mercury sphygmomanometer showed, 10 
that for four out of six devices accuracy deteriorated in the highest pressure category 11 
(>160/100 mmHg) [48]. 12 
Sex, age and AC were associated with device differences, too. Men had a higher SBP and DBP 13 
mean difference than women and the SBP difference increased with age for both sexes, 14 
whereas for DBP the difference non-significantly decreased with age. However, this 15 
observation is limited by the small sample size in the oldest age group. Sex-related differences 16 
were also reported elsewhere [18, 26, 49]. The effect of age on oscillometric BP measurement 17 
accuracy was often subject to investigation and is influenced by alterations in the viscoelastic 18 
structure of the arterial wall and the pulse pressure amplitude, i.e. the increase in arterial 19 
stiffness but also other factors that are associated with age (e.g. soft arm tissue, CW/AC-R, 20 
atrial fibrillation or heart rate) [50, 51].  21 
The different cuff sizes were associated with BP discrepancy. For the majority of persons, the 22 
Omron cuff was larger in relation to the AC than the corresponding Datascope cuff, reflected in 23 
a CW/AC-R difference >0%. Consequently, overcuffing due to a cuff size that is too big for a 24 
given AC [32, 35] was more likely with the Omron device. In fact, the measurement 25 
13 
 
disagreement was smaller if the Omron cuff was larger and especially the DBP difference was 1 
high within the few cases, where the Omron cuff was smaller than the Datascope cuff. 2 
Notably, overcuffing with Omron probably leads to an underestimation of BP. For this reason, 3 
the measurement disagreement could be even higher with better fitting Omron cuffs.  4 
 5 
Finally, oscillometric measurement accuracy is also affected by arterial stiffness [26, 29, 51, 52] 6 
Arterial stiffness may lead to broader plateaus and more complex shapes of oscillometric BP 7 
waveform [27, 51, 53] and may differentially influence oscillometric BP values calculated on 8 
the basis of device-specific algorithms. Indeed, the exact way of calculating SBP and DBP is 9 
proprietary and one cannot discern how a specific device model operates in the presence of 10 
arterial stiffness. We used pulse pressure as an indicator for arterial stiffness, because it tends 11 
to increase with stiffer arteries. The measurement difference in SBP increased with pulse 12 
pressure but the DBP difference, although not significant, decreased. Two other studies show 13 
similar results. One study found a strong correlation of SBP discrepancy with pulse pressure in 14 
patients with persistent unreliable oscillometric BP readings (device difference >10 mmHg in at 15 
least two clinic visits of an particular person) and there was a consistent trend for larger SBP 16 
differences across pulse pressure quintiles. Similar to our study, the differences in DBP 17 
decreased along pulse pressure quintiles [26]. In the other study an oscillometric Dinamap 18 
device overestimated SBP in patients with pulse pressures ≥60 mmHg (SBP difference 3.47 ± 19 
11.15 mmHg) whereas in general SBP was slightly underestimated (-0.52 ± 9.84 mmHg) [54]. 20 
The magnitude of DBP difference was smaller in persons with pulse pressure ≥60 mmHg 21 
compared to the overall sample.  22 
Moreover, two more studies support an effect of arterial stiffness on oscillometric BP 23 
measurement accuracy. Arterial stiffness was measured with carotid-femoral pulse wave 24 
velocity in one study and an increasing overestimation of SBP and DBP, obtained with a 25 
14 
 
Dinamap device in comparison to a random-zero sphygmomanometer, was found with 1 
increasing arterial stiffness  [29]. The other study observed a more severe overestimation of 2 
SBP in a group of insulin-dependent diabetics, known to have stiffer arteries, but a less severe 3 
underestimation of DBP in comparison with a mercury sphygmomanometer [55].  4 
 5 
A strength of this study is the relatively big sample size which exceeded the requirements set 6 
out in validation protocols (i.e. 85 subjects) and the well-balanced sample with regard to sex, 7 
age and BP distribution. Furthermore, the study design and standardization was compliant 8 
with the specifications of the ESH-IP2. Another positive finding was the large amount of 9 
explained variability. Accordingly, the conversion models operate well with just a few and 10 
easily available variables included.   11 
However, the difficulties in recruiting participants with high BP, especially high DBP, represent 12 
a limitation of our study. The defined BP range of the ESH-IP2 was not fulfilled and the 13 
conversion models may be less robust in the hypertensive BP range.  14 
However, the range close to the hypertension threshold (135-145/85-95 mmHg) is sufficiently 15 
reflected with our sample. Moreover, our results are not generalizable to children and 16 
adolescents since persons under 18 years were not included and also individuals with 17 
arrhythmia or a pacemaker were excluded and thus the device performance for these groups 18 
remains unclear. 19 
 20 
Last but not least, the possible implications of our results are of interest. We found a mean 21 
systolic measurement difference exceeding 2 mmHg, which is of a magnitude that is relevant 22 
at the population level. It has been estimated that 2-3 mmHg lower mean population SBP 23 
could reduce mortality from coronary heart disease by 4% to 5% and stroke mortality could be 24 
even more reduced by 6 to 8% [56].  25 
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Furthermore, in our study the hypertension prevalence measured with the Omron device was 1 
twice as high as with Datascope. This large difference may be due to the fact that many people 2 
have BP levels that are only marginally above or below the hypertension threshold. However, 3 
SBP measurements differed by more than 10 mmHg in more than one third of those above the 4 
hypertension threshold and in 20% of the elderly as well as of those in the highest tertile of 5 
pulse pressure. Such larger differences may result in differential treatment decisions 6 
suggesting that differences between oscillometric devices may be of particular clinical 7 
relevance in specific patient groups, such as geriatric patients or patients with diabetes and 8 
end stage renal disease [28, 53, 55, 57-59].  9 
 10 
In summary, our study suggests that BP values from different oscillometric devices may differ 11 
more than suggested by validation studies due to three reasons: (1) underestimation by one 12 
device and overestimation by the other device may add up, (2) manufacturer-provided cuffs 13 
may differ and lead to cuff-related BP measurement differences and (3) validation studies 14 
evaluate only overall agreement over a wide range of blood pressures and may mask more 15 
pronounced disagreement e.g. for measurements around and above hypertension threshold or 16 
measurements in patients with increased pulse pressure such as patients with diabetes or 17 
more generally in the elderly. This implies caution in the clinical care context when comparing 18 
measurements performed with different devices.  In clinical as well as epidemiological studies 19 
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Table 1: Characteristics of the study population 
  N unless stated 
otherwise 
% of measurement 
pairs 
Total completed (Total/Women/Men) 109 / 70 / 39  
Total measurement pairs (Total/Women/Men) 327 / 210 / 117 100 / 64 / 36 
Age <40/40-60/>60 years 49 / 48 / 12 45 / 44 / 11 
Proportion on BP lowering drugs 17 15.6 
Arm circumference mean ± SD (cm) 29.2 ± 3.6   
Omron HEM-705 CP II     
Arm circumference: cuff bladder sizes   
AC 22-31.9 cm: bladder 14x45 cm 89 81.7 
AC 32-42 cm: bladder 16x65 cm 20 18.3 
SBP mean ± SD (mmHg) 117.6 ± 15.5  
DBP mean ± SD (mmHg) 70.1 ± 10.1  
pulse pressure min / max / mean ± SD (mmHg)  23 / 87 / 47.6 ± 9.5  
CW/AC-R min / max / mean ± SD (%) 40 / 61 / 49.8 ± 4.8  
CL/AC-R min / max / mean ± SD (%) 71 / 100 / 83.3 ± 7.5   
Datascope Accutorr Plus     
Arm circumference: cuff bladder sizes   
AC 21 – 27.9: bladder 10.6x23.9 cm 34 31.2 
AC 28 – 35.9 cm: bladder 13.5x30.7 cm 71 65.1 
AC 36 – 46 cm: bladder 17.0x38.6 cm 4 3.7 
SBP mean ± SD (mmHg) 115.1 ± 13.9  
DBP mean ± SD (mmHg) 69.3 ± 9.4  
pulse pressure min / max / mean ± SD (mmHg) 27 / 78 / 45.8 ± 8.3  
CW/AC-R min / max / mean ± SD (%) 38 / 48 / 43.7 ± 3.0  
CL/AC-R min / max / mean ± SD (%) 87 / 110 / 99.2 ± 7.1   
CW/AC-R difference Omron - Datascope min / max / 
mean ± SD (%) 
-3 / 15 / 6.1 ± 5.5  
CL/AC-R difference Omron - Datascope min / max / 
mean ± SD (%) 
-28 / -3 / -15.9 ± 11.0   
CW/AC-R: cuff-width to arm-circumference ratio; CL/AC-R: cuff-length to arm-circumference ratio 
 
Table 2: Agreement between Omron HEM-705CP II and Datascope Accutorr Plus 
 
  
Difference Omron HEM-705 CP II – Datascope Accutorr 
Plus 
  N pairs 
% of 
pairs 












SBP 327  2.5 ± 5.7 66 91 98 0.000 
DBP 327  0.7 ± 3.5 89 99 100 0.000 
Sex        
SBP        
 
men 117 35.8 4.0 ± 6.1 56 87 97 0.000 
women 210 64.2 1.7 ± 5.3 72 93 99 0.000 
DBP       
 
men 117 35.8 1.3 ± 3.4 88 99 100 0.000 
women 210 64.2 0.4 ± 3.6 90 98 100 0.077 
Age              
SBP       
 
<40 years 147 45.0 2.4 ± 4.7 70 95 100 0.000 
40-60 years 144 44.0 2.2 ± 5.9 66 90 98 0.000 
>60 years 36 11.0 4.7 ± 8.0 53 81 89 0.003 
DBP        
 
<40 years 147 45.0 1.0 ± 3.8 87 99 100 0.001 
40-60 years 144 44.0 0.6 ± 3.4 91 98 100 0.054 
>60 years 36 11.0 0.0 ± 3.0 89 100 100 0.599 
Blood pressure (Omron)              
 SBP         
 
Optimal: ≤120 mmHg 188 57.5 1.1 ± 4.7 75 96 100 0.001 
Prehypertensive: 120-139 
mmHg) 107 32.7 3.0 ± 5.5 65 90 98 
0.000 
Hypertensive: ≥140 mmHg 32 9.8 9.3 ± 6.7 25 63 84 0.000 
Close to hypertension 
threshold: 135-145 mmHg 35 10.7 5.3± 6.6 46 77 94 
0.000 
DBP        
 
Optimal: ≤80 mmHg 261 79.8 0.2 ± 3.3 91 99 100 0.253 
Prehypertensive: 80-89 
mmHg 57 17.4 2.3 ± 3.4 83 100 100 
0.000 
Hypertensive: ≥90 mmHg 9 2.8 5.1 ± 3.9 78 89 100 0.008 
Close to hypertension 
threshold: 85-95 mmHg 30 9.2 3.4 ± 3.6 80 97 100 
0.000 
Pulse pressure (Omron)               
SBP       
 
<43 mmHg 116 35.5 0.2 ± 4.8 74 97 100 0.457 
43 – 50 mmHg 107 32.7 2.1 ± 4.6 74 94 100 0.000 
>50 mmHg 104 31.8 5.6 ± 6.3 50 81 93 0.000 
DBP       
 
<43 mmHg 116 35.5 1.1 ± 3.4  90 98 100 0.000 
43 – 50 mmHg 107 32.7 0.6 ± 3.9 87 97 100 0.074 
>50 mmHg 104 31.8 0.4 ± 3.3 90 100 100 0.497 
Arm circumference             
SBP       
 
<28 cm 102 31.2 1.9 ± 6.2 68 89 96 0.008 
28-35.9 cm 213 65.1 2.8 ± 5.6 65 91 99 0.000 
>36 cm 12 3.7 3.0 ± 3.7 75 100 100 0.016 
DBP    
   
 
<28 cm 102 31.2 -0.6 ± 3.4  91 98 100 0.170 
28-35.9 cm 213 65.1 1.1 ± 3.3 89 99 100 0.000 
>36 cm 12 3.7 4.1 ± 4.3 67 100 100 0.011 
CW/AC-R difference            
SBP         
≤0% 12 3.7 3.0 ± 3.7 75 100 100 0.016 




   
 
≤0% 12 3.7 4.1 ± 4.3 67 100 100 0.011 
>0%  315 96.3 0.6 ± 3.4 90 98 100 0.022 
CW/AC-R: cuff-width to arm-circumference ratio; CW/AC-R difference: CW/AC-R Omron HEM-705CP 
II – CW/AC-R Datascope Accutorr Plus 
 
Table 3: Linear regression models for the conversion of BP from Omron HEM-705CP II to Datascope 
Accutorr Plus and vice versa  
  Regression coefficient 
95% CI for regression 
coefficient 
Standardized 
coefficient p R² 
    Lower Limit Upper Limit       
Model 1: Prediction of Omron SBP from Datascope SBP 
Intercept 5.966 -0.551 12.482  0.073 
0.872 
Datascope SBP  1.050 0.980 1.119 0.942 0.000 
Datascope pulse 
pressure -0.150 -0.263 -0.037 -0.081 0.009 
Female sex -2.742 -4.204 -1.281 -0.085 0.000 
CW/AC-R difference -0.089 -0.203 0.025 -0.031 0.128 
Model 2: Prediction of Omron DBP from Datascope DBP 
Intercept -0.300 -3.518 2.917  0.854 
0.896 
Datascope DBP  0.953 0.913 0.993 0.889 0.000 
Datascope pulse 
pressure 0.117 0.074 0.161 0.097 0.000 
CW/AC-R difference  -0.180 -0.248 -0.113 0.098 0.000 
Model 3: Prediction of Datascope SBP from Omron SBP 
Intercept 3.046 -3.717 9.808  0.376 
0.885 
Omron SBP  0.975 0.919 1.032 1.087 0.000 
Omron pulse pressure -0.305 -0.392 -0.217 -0.209 0.000 
Arm circumference 0.036 0.017 0.054 0.093 0.000 
CW/AC-R difference  0.225 0.102 0.349 0.089 0.000 
Model 4: Prediction of Datascope DBP from Omron DBP 
Intercept 4.088 1.134 7.042  0.007 
0.888 
  
Omron DBP 0.859 0.819 0.898 0.920 0.000 
Omron pulse pressure  0.043 0.006 0.081 0.044 0.022 
Age 0.056 0.029 0.083 0.081 0.000 
CW/AC-R difference  0.111 0.044 0.177 0.065 0.001 
CW/AC-R: cuff-width to arm-circumference ratio; CW/AC-R difference: CW/AC-R Omron HEM-
705CP II – CW/AC-R Datascope Accutorr Plus 
 


